L Fodor Selected Research

Fumigant 93 (D-D)

1/2005	Endothelial nitric oxide synthase gene interactions and the risk of ischaemic stroke.
3/2004	Specific APO E genotypes in combination with the ACE D/D or MTHFR 677TT mutation yield an independent genetic risk of leukoaraiosis.
11/2001	Evaluation of the roles of common genetic mutations in leukoaraiosis.
9/2001	Evaluation of the roles of the Leiden V mutation and ACE I/D polymorphism in subtypes of ischaemic stroke.
8/2000	A clustering of unfavourable common genetic mutations in stroke cases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L Fodor Research Topics

Disease

3	Ischemic Stroke 01/2005 - 09/2001
2	Wounds and Injuries (Trauma) 10/2014 - 02/2011
2	Leukoaraiosis 03/2004 - 11/2001
1	Autism Spectrum Disorder 01/2017
1	Kleefstra Syndrome 01/2017
1	Autistic Disorder (Autism) 01/2017
1	Vaginal Discharge 02/2016
1	Burns 10/2014
1	Pain (Aches) 03/2012
1	Granuloma 07/2011
1	Spasm (Spasms) 02/2011
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2007
1	Fibrosarcoma 01/2007
1	Infections 06/2005
1	Weight Loss (Weight Reduction) 06/2005
1	Diabetes Mellitus 12/2003
1	Hypertension (High Blood Pressure) 12/2003
1	Dehydration (Water Stress) 10/2001
1	Weight Gain 10/2001
1	Infarction (Infarctions) 09/2001
1	Cerebral Infarction 09/2001
1	Stroke (Strokes) 08/2000
1	Pasteurella Infections (Pasteurellosis) 03/2000
1	Lung Abscess 01/2000

Drug/Important Bio-Agent (IBA)

5	Fumigant 93 (D-D)IBA 01/2005 - 08/2000
4	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2005 - 08/2000
4	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2005 - 08/2000
3	ApolipoproteinsIBA 03/2004 - 08/2000
2	valnemulinIBA 06/2005 - 10/2001
2	Apolipoproteins E (ApoE)IBA 03/2004 - 08/2000
2	Apolipoprotein E4IBA 03/2004 - 12/2003
2	Prothrombin (Factor II)IBA 12/2003 - 08/2000
1	Cholinergic Agents (Cholinergics)IBA 01/2017
1	Nonsense Codon (Nonsense Mutation)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 02/2016
1	CopperIBA 10/2014
1	AntigensIBA 07/2011
1	Transcription Factors (Transcription Factor)IBA 01/2007
1	Neurogenic differentiation factor 1IBA 01/2007
1	EnrofloxacinIBA 06/2005
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2005
1	Apolipoprotein E2IBA 03/2004
1	factor V LeidenIBA 12/2003
1	gamma-Aminobutyric Acid (GABA)IBA 10/2001
1	bicuculline methiodideIBA 10/2001
1	MuscimolIBA 10/2001
1	AnionsIBA 10/2001
1	Chlortetracycline (Aureomycin)FDA Link 10/2001
1	Lincomycin (Lincocin)FDA Link 10/2001
1	tilmicosinIBA 03/2000
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2000

Therapy/Procedure

1	Compression Bandages 10/2014
1	Pain Management 03/2012
1	Thrombectomy 02/2011
1	Catheters 02/2011
1	Free Tissue Flaps 02/2011
1	Therapeutics 01/2007